Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Petukhova EO, Gubaidullina LM, Krylova ES, Saifina LF, Lenina OA, Petrov KA (2020) <br />Novel Acetylcholinesterase Inhibitors Based on Uracil Moiety for Possible Treatment of Alzheimer Disease<br /><i>Molecules</i> <b>25</b>: <br /><br />Zueva IV, Dias J, Lushchekina SV, Semenov VE, Mukhamedyarov MA, Pashirova TN, Babaev VM, Nachon F, Petrova N, Nurullin LF, Zakharova LY, Ilyin VI, Masson P, Petrov KA (2019) <br />New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease<br /><i>Neuropharmacology</i> <b>155</b>: 131<br /><br />Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS (2015) <br />6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease<br /><i>ChemMedChem</i> <b>10</b>: 1863<br /><br />Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS (2015) <br />6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease<br /><i>Int J Risk Saf Med</i> <b>27 Suppl 1</b>: S69<br /><br />